Cargando…

Potential application of hydrogel to the diagnosis and treatment of multiple sclerosis

ABSTRACT: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system. This disorder may cause progressive and permanent impairment, placing significant physical and psychological strain on sufferers. Each progress in MS therapy marks a significant advancement in neurolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haochuan, Chen, Bing, Zhu, Qingsan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991948/ https://www.ncbi.nlm.nih.gov/pubmed/35395765 http://dx.doi.org/10.1186/s13036-022-00288-7

Ejemplares similares

Multiple sclerosis: Pathology, diagnosis and treatments
por: Huang, Wen-Juan, et al.
Publicado: (2017)

Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment
por: Rispoli, Marianna Gabriella, et al.
Publicado: (2021)

Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid
por: Karami Fath, Mohsen, et al.
Publicado: (2022)

Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
por: Elyaman, Wassim, et al.
Publicado: (2011)

Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges
por: Khan, Zuber, et al.
Publicado: (2023)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)

Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Differential Diagnosis of Pediatric Multiple Sclerosis
por: Galardi, Maria Milagros, et al.
Publicado: (2019)

Diagnosis and Management of Progressive Multiple Sclerosis
por: Macaron, Gabrielle, et al.
Publicado: (2019)

Evoked Potentials in Multiple Sclerosis Diagnosis and Management
por: CALUGARU, L., et al.
Publicado: (2016)

IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment
por: Sánchez-Vera, Isabel, et al.
Publicado: (2023)

Diagnosis and Management of Multiple Sclerosis in Children
por: NAJAFI, Mohammad Reza, et al.
Publicado: (2016)

Multiple Sclerosis and Serotonin: Potential Therapeutic Applications
por: San Hernandez, Aleyda M, et al.
Publicado: (2020)

Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
por: Jakimovski, Dejan, et al.
Publicado: (2021)

The diagnosis of multiple sclerosis and the clinical subtypes
por: Hurwitz, Barrie J.
Publicado: (2009)

An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
por: Garg, Neeta, et al.
Publicado: (2015)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Modern Technologies in the Rehabilitation of Patients with Multiple Sclerosis and Their Potential Application in Times of COVID-19
por: Zasadzka, Ewa, et al.
Publicado: (2021)

Glatiramer in the treatment of multiple sclerosis
por: Rizvi, Syed A, et al.
Publicado: (2006)

Natalizumab in the treatment of multiple sclerosis
por: Brown, Brandon A
Publicado: (2009)

Alemtuzumab in the treatment of multiple sclerosis
por: Fernandez, Óscar
Publicado: (2014)

Alemtuzumab for the treatment of multiple sclerosis
por: Willis, Mark D, et al.
Publicado: (2015)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
por: Lo Sasso, Bruna, et al.
Publicado: (2019)

Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies
por: Yeh, E Ann
Publicado: (2010)

Cognitive Fatigue in Multiple Sclerosis: An Objective Approach to Diagnosis and Treatment by Transcranial Electrical Stimulation
por: Linnhoff, Stefanie, et al.
Publicado: (2019)

Noncoding RNAs in multiple sclerosis
por: Yang, Xuan, et al.
Publicado: (2018)

The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review
por: Jia, Dongmei, et al.
Publicado: (2022)

Potential Biomarkers Associated with Multiple Sclerosis Pathology
por: Mathur, Deepali, et al.
Publicado: (2021)

Assessment of Motor Evoked Potentials in Multiple Sclerosis
por: Šoda, Joško, et al.
Publicado: (2023)

Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis
por: Portaccio, Emilio
Publicado: (2011)

Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis
por: Reardon, Jennifer, et al.
Publicado: (2013)

From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
por: Raghib, Muhammad Faraz, et al.
Publicado: (2023)

The potential applications of microparticles in the diagnosis, treatment, and prognosis of lung cancer
por: Liu, Yu, et al.
Publicado: (2022)

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
por: Wei, Weipeng, et al.
Publicado: (2021)

The Dual Effect of 3D-Printed Biological Scaffolds Composed of Diverse Biomaterials in the Treatment of Bone Tumors
por: Ma, Yihang, et al.
Publicado: (2023)

Nanocomposite hydrogels for biomedical applications
por: Huang, Shanghui, et al.
Publicado: (2022)

Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article
por: Zimek, Dalibor, et al.
Publicado: (2023)

Differential diagnosis of suspected multiple sclerosis: a consensus approach
por: Miller, DH, et al.
Publicado: (2008)

Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist
por: Baskaran, Archit B, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_igidqsvegqoj3mb70guiv8iqrr